HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularization.

Abstract
Previous studies have shown a good outcome for patients who present with normal findings on stress myocardial perfusion imaging. Currently, the prognostic implications of a normal study in patients who have a history of coronary artery disease (CAD) are not clear. This study investigated the long-term prognosis after a normal finding on stress technetium-99m (Tc-99m)-tetrofosmin single-photon emission computed tomography in patients with a history of CAD. The study included 147 consecutive patients with a history of CAD (previous myocardial infarction and/or myocardial revascularization), who underwent exercise bicycle or high-dose dobutamine-atropine stress Tc-99m-tetrofosmin single-photon emission computed tomography, and had normal perfusion results during stress and at rest. Follow-up was completed in all patients. During a follow-up of 6.5 +/- 1.9 years, 20 patients (14%) died, 10 (7%) of whom died due to cardiac causes, and 12 (8%) had a nonfatal myocardial infarction. Annual cardiac death rates were 0.5% during the first 3 years of follow-up and 1.3% in the subsequent 3 years. Independent predictors of cardiac death were male gender, rate-pressure product at rest, and rate-pressure product at peak stress. In conclusion, patients who have a history of CAD have a very low cardiac death rate during the 3 years after a normal finding on stress Tc-99m-tetrofosmin single-photon emission computed tomography. Repeated testing should be reconsidered 3 years after the initial evaluation and when a change in symptoms or clinical condition occurs.
AuthorsArend F L Schinkel, Abdou Elhendy, Jeroen J Bax, Ron T van Domburg, Aukje Huurman, Roelf Valkema, Elena Biagini, Vittoria Rizzello, Harm H Feringa, Eric P Krenning, Maarten L Simoons, Don Poldermans
JournalThe American journal of cardiology (Am J Cardiol) Vol. 97 Issue 1 Pg. 1-6 (Jan 01 2006) ISSN: 0002-9149 [Print] United States
PMID16377272 (Publication Type: Journal Article)
Chemical References
  • Organophosphorus Compounds
  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • technetium tc-99m tetrofosmin
Topics
  • Aged
  • Blood Pressure
  • Coronary Artery Disease (mortality, therapy)
  • Coronary Circulation
  • Echocardiography, Stress
  • Exercise Test
  • Female
  • Follow-Up Studies
  • Heart Rate
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Myocardial Infarction (diagnostic imaging, mortality, therapy)
  • Myocardial Revascularization
  • Organophosphorus Compounds
  • Organotechnetium Compounds
  • Prognosis
  • Radiopharmaceuticals
  • Sex Factors
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: